Vector Laboratories Acquires Quanta BioDesign
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Stay updated with breaking news from Vector Laboratories. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Based in Newark, California, Vector Laboratories is a provider of consumable reagents used in slide staining and imaging workflows within life science research.
Quanta BioDesign was founded with a focus on developing and commercializing a line of dPEG-based products for companies in drug discovery and diagnostic development programs.
Beginning in the first trimester, fetally derived extravillous trophoblasts (EVTs) invade the uterus and remodel its spiral arteries, transforming them into large, dilated blood vessels. Several mechanisms have been proposed to explain how EVTs coordinate with the maternal decidua to promote a tissue microenvironment conducive to spiral artery remodelling (SAR)1–3. However, it remains a matter of debate regarding which immune and stromal cells participate in these interactions and how this evolves with respect to gestational age. Here we used a multiomics approach, combining the strength...
/PRNewswire/ -- The global magnetic beads market size is estimated to increase by USD 1,672.62 million from 2022 to 2027. The market's growth momentum will...